| Literature DB >> 27740624 |
Christina Stoeckle1, Barbara Geering1, Shida Yousefi1, Saša Rožman1, Nicola Andina1, Charaf Benarafa2, Hans-Uwe Simon1.
Abstract
Eosinophils are frequently elevated in pathological conditions and can cause tissue damage and disease exacerbation. The number of eosinophils in the blood is largely regulated by factors controlling their production in the bone marrow. While several exogenous factors, such as interleukin-5, have been described to promote eosinophil differentiation, comparatively little is known about eosinophil-intrinsic factors that control their de novo generation. Here, we report that the small atypical GTPase RhoH is induced during human eosinophil differentiation, highly expressed in mature blood eosinophils and further upregulated in patients suffering from a hypereosinophilic syndrome. Overexpression of RhoH increases, in a Rho-associated protein kinase-dependent manner, the expression of GATA-2, a transcription factor involved in regulating eosinophil differentiation. In RhoH-/- mice, we observed reduced GATA-2 expression as well as accelerated eosinophil differentiation both in vitro and in vivo. Conversely, RhoH overexpression in bone marrow progenitors reduces eosinophil development in mixed bone marrow chimeras. These results highlight a novel negative regulatory role for RhoH in eosinophil differentiation, most likely in consequence of altered GATA-2 levels.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27740624 PMCID: PMC5136485 DOI: 10.1038/cdd.2016.73
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828